Skip to main content

NCBiotech News

  • If dengue, chikungunya, West Nile and about 200 other mosquito-carried viruses have you concerned, you're in luck. North Carolina is the world vaccine leader. This top-tier bioscience state goes viral when vaccines are the topic.
  • The United Nations projects that by 2050, we’ll have nine billion people in the world. Those additional 1.8 billion people will need to eat. Where will all that food come from? It’s a question that North Carolina companies are researching in earnest. 
  • A $1.8 million federal grant has been awarded to the City of Clinton to help pay for water and sewer hookups to a planned $200 million investment: a 20-million-gallon-a-year cellulosic biofuel refinery in the Sampson County community.
  • North Carolina reigns, after more than three decades of growth and change in the industry, as the CRO epicenter of the world.
  • Seven years after construction began on the $1 billion Novartis Holly Springs cell culture vaccine manufacturing facility, federal regulators have approved the factory’s output of the revolutionary Flucelvax flu vaccine for sale in the United States.
  • Weekly Grant Funding Opportunities
  • Heat Biologics has come a long way in a short time. But the most recent part of that journey was just a few miles down the road, to the biopharmaceutical company’s new Durham headquarters and lab facility on Capitola Drive. That move will be celebrated in a July open house.
  • If you're launching an NC life science company, Friday, June 20 is the deadline for applications to pitch your company story to investors and colleagues at the 16th annual Southeast BIO Investor & Partnering Forum, to be held November 11-13 in Atlanta.
  • Weekly Grant Funding Opportunities
  • Weekly Grant Funding Opportunities
  • ECU scientists are excited they'll soon take delivery of an Ion Proton DNA sequencer to benefit collaborators from across the university, purchased with a $149,000 NCBiotech grant.
  • BioCryst moved its company headquarters to Durham from Alabama four years ago, and now the publicly traded clinical-stage pharmaceutical company is reporting positive results from an important clinical trial.
  • Weekly Grant Funding Opportunities
  • Nine ag biotech business leaders pitched their companies’ assets to more than 150 participants in the Ag Biotech Entrepreneurial Showcase 2014 Tuesday at NCBiotech. The event also included panel discussions and two keynote speeches by CEOs of two high-tech food companies.      
  • Weekly Grant Funding Opportunities
  • Nine entrepreneurial ag-related companies from North Carolina and three other Southeastern states will take the North Carolina Biotechnology Center stage Tuesday, May 20, for the Ag Biotech Entrepreneurial Showcase 2014.
  • Weekly Grant Funding Opportunities
  • Charlotte pharmaceutical company Chelsea Therapeutics is being purchased by Danish global drug company Lundbeck for as much as $658 million in up-front cash and milestone payments to shareholders.
  • The North Carolina Biotechnology Center awarded nearly $2.5 million in the third quarter of its 2013-2014 fiscal year, while the Center’s loan recipients brought in more than $192 million in outside funding during the period.
  • Durham's Novan Therapeutics is one of only four companies whose executives have been invited to give 15-minute presentations at the 2014 BIO International Convention in San Diego next month.


Subscribe to News & Events